World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Inozyme Pharma Inc.

    World Rank (Jan-05-2024)
    16,447
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    17,663
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    25,394
    Market Cap (Dec-25-2022)
    0.048 Billion USD
    World Rank (Jan-07-2022)
    20,454
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    USA
    Company Profile
    Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
    Company Website
    INOZYME PHARMA, INC.

  2. Atea Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    16,476
    Market Cap (Jan-05-2024)
    0.264 Billion USD
    World Rank (Jul-30-2023)
    16,155
    Market Cap (Jul-30-2023)
    0.284 Billion USD
    World Rank (Dec-25-2022)
    14,183
    Market Cap (Dec-25-2022)
    0.382 Billion USD
    World Rank (Jan-07-2022)
    11,890
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    351 Million USD
    Annual Net Income in USD
    121 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Atea is a Clinical Stage Biopharmaceutical company. It is focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life threatening viral diseases. The company annual revenue is 13.6 million USD and 6,904 employees as on 2019. The headquarters is in USA.
    Company Website
    ATEA PHARMACEUTICALS, INC.

  3. Esperion Therapeutics

    World Rank (Jan-05-2024)
    16,515
    Market Cap (Jan-05-2024)
    0.262 Billion USD
    World Rank (Jul-30-2023)
    19,737
    Market Cap (Jul-30-2023)
    0.145 Billion USD
    World Rank (Dec-25-2022)
    13,138
    Market Cap (Dec-25-2022)
    0.447 Billion USD
    World Rank (Jan-07-2022)
    17,467
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    227 Million USD
    Annual Net Income in USD
    -143 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Esperion Therapeutics is a Pharmaceutical company. The headquarters is in USA.
    Company Website
    ESPERION THERAPEUTICS INC

  4. Heron Therapeutics

    World Rank (Jan-05-2024)
    16,547
    Market Cap (Jan-05-2024)
    0.260 Billion USD
    World Rank (Jul-30-2023)
    18,406
    Market Cap (Jul-30-2023)
    0.187 Billion USD
    World Rank (Dec-25-2022)
    15,577
    Market Cap (Dec-25-2022)
    0.306 Billion USD
    World Rank (Jan-07-2022)
    10,044
    Market Cap (Jan-07-2022)
    0.89 Billion USD
    Annual Revenue in USD
    86 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Heron Therapeutics is a Developing and Commercializing Pharmaceutical Products company. The headquarters is in USA.
    Company Website
    HERON THERAPEUTICS INC

  5. Rigel Pharmaceuticals

    World Rank (Jan-05-2024)
    16,563
    Market Cap (Jan-05-2024)
    0.260 Billion USD
    World Rank (Jul-30-2023)
    17,262
    Market Cap (Jul-30-2023)
    0.231 Billion USD
    World Rank (Dec-25-2022)
    17,697
    Market Cap (Dec-25-2022)
    0.213 Billion USD
    World Rank (Jan-07-2022)
    14,363
    Market Cap (Jan-07-2022)
    0.43 Billion USD
    Annual Revenue in USD
    109 Million USD
    Annual Net Income in USD
    -30 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Rigel Pharmaceuticals is a Biotechnology company focused on hematologic disorders, cancer and rare immune diseases. The company annual revenue is 133.9 million USD and 158 employees as on 2020. The headquarters is in USA.
    Company Website
    RIGEL PHARMACEUTICALS

  6. Progenity Inc.

    World Rank (Jan-05-2024)
    16,614
    World Rank (Jul-30-2023)
    16,614
    World Rank (Dec-25-2022)
    16,614
    World Rank (Jan-07-2022)
    16,614
    Market Cap (Jan-07-2022)
    0.31 Billion USD
    Headquarters Country
    USA
    Company Website
    PROGENITY, INC.

  7. Clovis Oncology

    World Rank (Jan-05-2024)
    16,624
    World Rank (Jul-30-2023)
    16,624
    World Rank (Dec-25-2022)
    16,624
    World Rank (Jan-07-2022)
    16,624
    Market Cap (Jan-07-2022)
    0.30 Billion USD
    Annual Revenue in USD
    165 Million USD
    Annual Net Income in USD
    -369 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    CLOVIS ONCOLOGY is a Biotechnology company working related to cancer treatment. Headquarters is in USA.
    Company Website
    CLOVIS ONCOLOGY INC
    Wikipedia
    Wikipedia

  8. Foghorn Therapeutics Inc.

    World Rank (Jan-05-2024)
    16,628
    Market Cap (Jan-05-2024)
    0.256 Billion USD
    World Rank (Jul-30-2023)
    14,496
    Market Cap (Jul-30-2023)
    0.378 Billion USD
    World Rank (Dec-25-2022)
    17,091
    Market Cap (Dec-25-2022)
    0.238 Billion USD
    World Rank (Jan-07-2022)
    11,175
    Market Cap (Jan-07-2022)
    0.74 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Net Income in USD
    -101 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile
    Foghorn Therapeutics Inc. is Developing Therapies designed to modulate the chromatin regulatory system company. The company estimated annual revenue is currently 17.8 million USD per year and 85 employees as on 2020. The headquarters is in USA.
    Company Website
    FOGHORN THERAPEUTICS INC.

  9. Enanta Pharmaceuticals

    World Rank (Jan-05-2024)
    16,659
    Market Cap (Jan-05-2024)
    0.254 Billion USD
    World Rank (Jul-30-2023)
    14,315
    Market Cap (Jul-30-2023)
    0.388 Billion USD
    World Rank (Dec-25-2022)
    8,465
    Market Cap (Dec-25-2022)
    0.979 Billion USD
    World Rank (Jan-07-2022)
    7,749
    Market Cap (Jan-07-2022)
    1.40 Billion USD
    Annual Revenue in USD
    97 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    Sep-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Enanta Pharmaceuticals is a Clinical Stage Biotechnology company. It is a robust chemistry driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for viral infections and liver diseases. The company annual revenue is 205.2 million USD and 132 employees as on 2020. The headquarters is in USA.
    Company Website
    ENANTA PHARMACEUTICALS INC

  10. Oxford Biomedica

    World Rank (Jan-05-2024)
    16,733
    Market Cap (Jan-05-2024)
    0.250 Billion USD
    World Rank (Jul-30-2023)
    12,183
    Market Cap (Jul-30-2023)
    0.545 Billion USD
    World Rank (Dec-25-2022)
    12,381
    Market Cap (Dec-25-2022)
    0.502 Billion USD
    World Rank (Jan-07-2022)
    8,157
    Market Cap (Jan-07-2022)
    1.28 Billion USD
    Annual Revenue in USD
    179 Million USD
    Annual Operating Income in USD
    -66 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    UK
    Yahoo @ Frankfurt
    Company Profile

    Oxford Biomedica is a Pioneer of gene and cell therapy with a position in Lentiviral Vector Research, Development and Bioprocessing company. It have created a valuable portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders and provide with multiple income streams, consisting of upfront milestone payments, development and production fees and potential royalties on future product sales. The headquarters is in UK.

    Company Website
    OXFORD BIOMEDICA
    Wikipedia
    Wikipedia

Share